A community-based approach to new antibiotic discovery

Abstract

The Community for Open Antimicrobial Drug Discovery aims to tap into the potential of the millions of compounds distributed around laboratories globally to be a source of new antibiotic leads by offering free screening for antimicrobial properties, with no strings attached.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Cooper, M. A. & Shlaes, D. A. Fix the antibiotics pipeline. Nature, 472, 32 (2011).

  2. 2

    Payne, D. J. et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29–40 (2007).

  3. 3

    Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371–387 (2013).

  4. 4

    Shushko, I. et al. ToxAlerts: a web server of structural alerts for toxic chemicals and compounds with potential adverse reactions. J. Chem. Inf. 52, 2310–2316 (2012).

  5. 5

    O'Shea, R. & Moser, H. E. Physicochemical properties of antibacterial compounds: implications for drug discovery. J. Med. Chem. 51, 2871–2878 (2008).

Download references

Author information

Correspondence to Matthew A. Cooper.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Related links

Related links

FURTHER INFORMATION

CO-ADD

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cooper, M. A community-based approach to new antibiotic discovery. Nat Rev Drug Discov 14, 587–588 (2015). https://doi.org/10.1038/nrd4706

Download citation

Further reading